Guo Y et al. [33] found that genistein can inhibit connective tissue growth factor expression and slow down the process of epithelial-to-mesenchymal transition, thus showing therapeutic potential against renal transdifferentiation and fibrogenesis in PTH-induced end-stage renal disease. The gene discussed is PTH; the disease is stage 5 chronic kidney disease.